Management
Michele Migliuolo, Ph.D.
President and COO, Director
Dr. Migliuolo received a Doctorate in Physics from the University of Rome (Italy), and M.A. and Ph.D. degrees in Physics from the University of Rochester. He has twenty years experience as an executive in manufacturing and sales of scientific capital equipment and analytical instruments. He has launched foreign products in the United States including mass spectrometers, and imaging chemical microscopes and has launched American products abroad, including thin film deposition systems and surface analysis systems. His expertise is with worldwide customers ranging from academic-government research laboratories, to medical device, semiconductor, superconductor, data storage, electro-optic, microscopy, and analytical chemistry industries. Previously, he was Vice President of Technology at the Kurt J. Lesker Company, Vice President of Sales and Marketing at E.A. Fischione Instruments Inc., and President of XACTIX. Most recently, his experience includes positions at The Pittsburgh Life Sciences Greenhouse, Seagate Technology, Vice President at Powercast, and Founder and CEO of Verimetra, Inc., a startup manufacturer of MEMS biomedical devices and sensors.
President and COO, Director
Dr. Migliuolo received a Doctorate in Physics from the University of Rome (Italy), and M.A. and Ph.D. degrees in Physics from the University of Rochester. He has twenty years experience as an executive in manufacturing and sales of scientific capital equipment and analytical instruments. He has launched foreign products in the United States including mass spectrometers, and imaging chemical microscopes and has launched American products abroad, including thin film deposition systems and surface analysis systems. His expertise is with worldwide customers ranging from academic-government research laboratories, to medical device, semiconductor, superconductor, data storage, electro-optic, microscopy, and analytical chemistry industries. Previously, he was Vice President of Technology at the Kurt J. Lesker Company, Vice President of Sales and Marketing at E.A. Fischione Instruments Inc., and President of XACTIX. Most recently, his experience includes positions at The Pittsburgh Life Sciences Greenhouse, Seagate Technology, Vice President at Powercast, and Founder and CEO of Verimetra, Inc., a startup manufacturer of MEMS biomedical devices and sensors.
Lawrence Wechsler, M.D.
Chair Strategic Advisory Board
Dr. Wechsler is professor of neurology and neurological surgery at the University of Pittsburgh School of Medicine, is director of the University of Pittsburgh Medical Center (UPMC) Stroke Institute and has been very active in the treatment of stroke and its debilitating effects. He was among the first doctors to report on the direct intra-arterial injection of urokinase to dissolve blood clots in brains of people suffering stroke. He is co-editor of one of the leading texts on transcranial doppler ultrasound, a method that uses a microprocessor-controlled adjustable probe that records blood flow in intracranial arteries.
Chair Strategic Advisory Board
Dr. Wechsler is professor of neurology and neurological surgery at the University of Pittsburgh School of Medicine, is director of the University of Pittsburgh Medical Center (UPMC) Stroke Institute and has been very active in the treatment of stroke and its debilitating effects. He was among the first doctors to report on the direct intra-arterial injection of urokinase to dissolve blood clots in brains of people suffering stroke. He is co-editor of one of the leading texts on transcranial doppler ultrasound, a method that uses a microprocessor-controlled adjustable probe that records blood flow in intracranial arteries.
Ender Finol Ph. D.
Vice President, Engineering
Dr Finol is associate research professor for the Institute for Complex Engineered Systems and Biomedical Engineering Department at Carnegie Mellon University, operates the Vascular Biomechanics and Biofluids Laboratory. His primary research interest is in the dynamics of blood flow and its relationship with disease. In his laboratory, this interest drives research projects with a basis on soft tissue biomechanics, fluid mechanics as related to medical applications, computational mechanics for cardiovascular diseases, design and optimization of medical devices, and algorithm development for 3D segmentation and reconstruction of medical images. Dr. Finol is very active within the vascular biofluids and biomechanics scientific community, in particular with the Bioengineering Division of the American Society of Mechanical Engineers (ASME).
Vice President, Engineering
Dr Finol is associate research professor for the Institute for Complex Engineered Systems and Biomedical Engineering Department at Carnegie Mellon University, operates the Vascular Biomechanics and Biofluids Laboratory. His primary research interest is in the dynamics of blood flow and its relationship with disease. In his laboratory, this interest drives research projects with a basis on soft tissue biomechanics, fluid mechanics as related to medical applications, computational mechanics for cardiovascular diseases, design and optimization of medical devices, and algorithm development for 3D segmentation and reconstruction of medical images. Dr. Finol is very active within the vascular biofluids and biomechanics scientific community, in particular with the Bioengineering Division of the American Society of Mechanical Engineers (ASME).
Karen Davis
Interim Vice President, Clinical Affairs
Ms. Davis has been in the medical device industry for over twenty years, including thirteen years in interventional neuro with ev3 Neurovascular and Micro Therapeutics. Her experience has included positions in marketing, business development, and clinical research. Ms. Davis was Sr. Director of Clinical Affairs at ev3 Neurovascular. As head of the neuro clinical department, her responsibilities included implementation and management of all clinical studies worldwide. Her neuro product experience has included intracranial stents, liquid embolic materials, embolic coils, intracranial occlusion balloons, microcatheters, and microguidewires. Ms. Davis also served as Director of Business Development for Intersect Partners, a medical device incubator. In this position she was responsible for origination, analysis and presentation of new business opportunities to venture capitalists and other potential funding sources. Ms. Davis began her career on Wall Street with both Merrill Lynch and Needham & Company, where she was Vice President Corporate Finance and head of the Healthcare Investment Banking Group. Ms. Davis holds a BA in Mathematics from Colorado College, and an MBA from Stanford University.
Interim Vice President, Clinical Affairs
Ms. Davis has been in the medical device industry for over twenty years, including thirteen years in interventional neuro with ev3 Neurovascular and Micro Therapeutics. Her experience has included positions in marketing, business development, and clinical research. Ms. Davis was Sr. Director of Clinical Affairs at ev3 Neurovascular. As head of the neuro clinical department, her responsibilities included implementation and management of all clinical studies worldwide. Her neuro product experience has included intracranial stents, liquid embolic materials, embolic coils, intracranial occlusion balloons, microcatheters, and microguidewires. Ms. Davis also served as Director of Business Development for Intersect Partners, a medical device incubator. In this position she was responsible for origination, analysis and presentation of new business opportunities to venture capitalists and other potential funding sources. Ms. Davis began her career on Wall Street with both Merrill Lynch and Needham & Company, where she was Vice President Corporate Finance and head of the Healthcare Investment Banking Group. Ms. Davis holds a BA in Mathematics from Colorado College, and an MBA from Stanford University.